Physician profile
Pamela J Howard
NPI 1982726493
$13,643.82
in general payments reported to CMS, 2019-2025
66 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what 82% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,783 · 2020: $1,920 · 2021: $1,615 · 2022: $1,910 · 2023: $1,462 · 2024: $2,481 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,217 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,217.49 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,403.63 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $1,355.77 | 2019-2025 | Rylaze |
| Teva Pharmaceuticals USA, INC. | $660.57 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Harmony Biosciences LLC | $620.05 | 2020-2025 | Wakix |
| Lilly USA, LLC | $597.20 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Lundbeck LLC | $586.03 | 2020-2025 | Vyepti, Rexulti |
| Amgen INC. | $581.20 | 2019-2022 | |
| Ucb, INC. | $542.46 | 2019-2025 | Rystiggo, Nayzilam, Briviact |
| Eisai INC. | $457.72 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $441.93 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $405.67 | 2022 | |
| Biogen, INC. | $383.07 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Pfizer INC. | $377.25 | 2023-2025 | |
| Emd Serono, INC. | $360.19 | 2020-2025 | |
| Upsher-Smith Laboratories LLC | $337.65 | 2020-2022 |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.